Delay in reforming European rules could deny thousands of children access to latest cancer drugs 22 Dec 2017 Thousands of children with cancer across Europe could miss out on the latest targeted treatments because of delays reforming outdated regulations, leading cancer research institutions, charities and expert bodies are warning. Find out more Show/Hide
New resource to challenge widespread poor practice in biomedical researchers’ use of chemical probes 12 Dec 2017 Details of a major new online resource designed to improve biomedical research by helping researchers choose the best chemical probes for their experiments – allowing drug targets to be validated much more effectively – have been published today. Find out more Show/Hide
ICR awarded major prize for pioneering discoveries in precision medicines for cancer 01 Dec 2017 The Institute of Cancer Research, London, has been recognised with a highly prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery. Find out more Show/Hide
European Medicines Agency approves abiraterone combined with hormone therapy as first-line treatment for advanced prostate cancer 22 Nov 2017
ICR responds to NICE approval of new breakthrough drugs on the NHS for women with advanced breast cancer 16 Nov 2017
New blood test detects early resistance to BRCA-targeting drugs for breast and ovarian cancer 02 Nov 2017